Back to NRIX
Redmile Group, LLC NRIX Position History
Nurix Therapeutics, Inc.
Quarters held
4
Latest value
$187.3M
Q3 2026
Peak value
$187.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $153.5M |
| Q1 2026 | $119.9M |
| Q2 2026 | $98.8M |
| Q3 2026 | $187.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $187.3M | 7.90M | — | — |
| Q2 2026 | $98.8M | 4.07M | — | — |
| Q1 2026 | $119.9M | 7.73M | — | — |
| Q4 2025 | $153.5M | 8.09M | — | — |
Other funds holding NRIX
$195.3M
$187.7M
$175.3M
$166.6M
$164.8M
$142.3M
$133.5M